coronavirus
larg
envelop
posit
strand
rnavirus
viral
rna
genom
kb
size
cap
polyadenyl
encapsid
helic
nucleocapsid
envelop
stud
long
petalshap
spike
give
viru
particl
characterist
crownlik
appear
three
distinct
group
coronavirus
describ
base
serolog
affin
genom
sequenc
coronavirus
infect
human
varieti
domest
anim
caus
highli
preval
diseas
respiratori
enter
cardiovascular
neurolog
disord
recent
three
human
coronavirus
thoroughli
studi
human
coronaviru
group
human
coronaviru
group
identifi
respons
common
cold
infect
occur
mainli
winter
earli
spring
third
novel
human
coronaviru
sarscov
identifi
causal
agent
outbreak
sever
acut
respiratori
syndrom
sar
phylogenet
analysi
show
sarscov
close
resembl
three
previous
known
group
coronavirus
therefor
tent
fourth
group
coronavirus
suggest
howev
earli
splitoff
sarscov
coronaviru
group
lineag
also
suggest
new
human
coronaviru
associ
respiratori
ill
recent
identifi
research
team
netherland
viru
isol
januari
nasopharyng
aspir
child
suffer
bronchiol
conjunct
fever
screen
specimen
patient
respiratori
symptom
identifi
seven
addit
infect
individu
children
adult
decemb
februari
complet
viral
genom
sequenc
determin
characterist
genom
organis
coronavirus
observ
twothird
genom
contain
two
larg
open
read
frame
orf
part
genom
gene
encod
four
structur
protein
found
spike
envelop
e
membran
nucleocapsid
n
hemagglutininesteras
gene
characterist
group
coronavirus
present
sequenc
analysi
demonstr
share
sequenc
ident
phylogenet
analysi
confirm
new
group
coronaviru
close
relat
porcin
epidem
diarrhea
viru
pedv
shortli
van
der
hoek
colleagu
publish
discoveri
new
human
coronaviru
second
research
group
describ
character
essenti
viru
viru
isol
nose
swab
sampl
collect
child
suffer
pneumonia
netherland
april
realtim
rtpcr
assay
design
screen
respiratori
tract
sampl
four
addit
posit
sampl
children
age
month
year
detect
novemb
januari
consid
new
import
caus
respiratori
ill
two
differ
subtyp
might
current
cocircul
human
popul
studi
want
explor
incid
infect
children
diagnos
respiratori
tract
infect
belgium
studi
isol
patient
sever
respiratori
symptom
collect
januari
march
univers
hospit
leuven
belgium
isol
origin
bronchoalveolar
lavag
pharyng
swab
nasopharyng
aspir
sputum
sampl
routin
diagnost
test
perform
respiratori
syncyti
viru
rsv
influenza
viru
parainfluenza
viru
adenoviru
prior
amplif
cell
cultur
perform
result
diagnost
test
rsv
neg
isol
isol
posit
rsv
patient
rang
age
month
year
mean
age
year
tempor
distribut
isol
correspond
yearli
rsv
epidem
period
sampl
collect
januari
june
sampl
recov
first
trimest
figur
rna
extract
collect
specimen
use
qiaamp
viral
rna
mini
kit
qiagen
westburg
netherland
accord
instruct
manufactur
screen
sampl
perform
amplifi
bp
fragment
polymeras
gene
use
follow
primer
set
corfw
corrv
figur
onestep
rtpcr
assay
onestep
rtpcr
kit
qiagen
undertaken
reaction
volum
contain
rnaextract
qiagen
onestep
rtpcr
buffer
dntp
mix
final
concentr
dntp
qiagen
onestep
rtpcr
enzym
mix
combin
omniscript
sensiscript
revers
transcriptas
hotstartaq
dna
polymeras
primer
rnasefre
water
reaction
carri
initi
revers
transcript
step
min
follow
pcr
activ
min
cycl
amplif
sec
sec
min
final
extens
step
min
geneamp
pcr
system
thermal
cycler
appli
biosystem
foster
citi
ca
usa
pcrproduct
run
polyacrylamid
gel
stain
ethidium
bromid
visual
uvlight
sampl
found
posit
confirm
use
onestep
rtpcr
assay
amplifi
four
differ
region
genom
amplif
gene
fragment
nucleocapsid
region
perform
two
specif
primer
nt
nt
secondli
fragment
amplifi
use
primer
describ
van
der
hoek
colleagu
third
rtpcr
assay
carri
posit
sampl
amplifi
fragment
specif
primer
onestep
rtpcr
assay
perform
essenti
describ
carri
use
rnaextract
primer
cycl
amplif
run
anneal
temperatur
set
furthermor
bp
fragment
spike
gene
amplifi
use
rtnest
pcr
outer
primer
set
nt
nt
use
onestep
rtpcr
perform
describ
use
rnaextract
anneal
temperatur
nest
pcr
carri
inner
primer
set
nt
nt
nest
reaction
mix
compos
unit
taq
polymeras
mm
dntpmix
buffer
c
pcr
optim
kit
invitrogen
netherland
pmol
forward
revers
primer
reaction
volum
templat
outer
pcr
product
ad
cycl
condit
follow
initi
denatur
min
follow
cycl
amplif
sec
sec
min
final
extens
min
pcrproduct
run
polyacrylamid
gel
stain
ethidium
bromid
visual
uvlight
amplicon
purifi
use
qiaquick
pcr
purif
kit
qiagen
sequenc
respect
primer
pair
use
abi
prism
bigdy
termin
cycl
sequenc
reaction
kit
version
abi
prism
dna
sequenc
appli
biosystem
accord
manufactur
instruct
posit
neg
control
includ
pcr
experi
posit
control
rna
isol
cultur
chromatogram
sequenc
file
inspect
chroma
technelysium
pti
ltd
helensval
australia
contig
prepar
use
seqman
ii
dnastar
madison
wi
usa
obtain
consensu
sequenc
compar
prototyp
sequenc
avail
genbank
databas
releas
use
blast
analysi
ncbi
blast
server
multipl
sequenc
align
prepar
use
clustal
x
version
manual
edit
genedoc
align
editor
phylogenet
analysi
conduct
use
mega
version
sequenc
determin
studi
deposit
genbank
sequenc
databas
access
number
collect
sampl
also
screen
use
pancoronaviru
rtpcr
assay
presenc
posit
result
confirm
onestep
rtpcr
use
specif
primer
pair
locat
membran
glycoprotein
region
nt
nt
nt
nt
onestep
rtpcr
sequenc
analysi
perform
essenti
describ
anneal
condit
rtpcr
assay
modifi
anneal
temperatur
set
pancoronaviru
rtpcr
assay
useful
tool
test
coronavirus
clinic
sampl
besid
quick
screen
sever
pathogen
one
assay
suppli
possibl
identifi
previous
unknown
coronavirus
consensu
rtpcr
assay
describ
stephensen
et
al
design
amplifi
known
coronavirus
abl
detect
sever
mismatch
primer
sequenc
modifi
consensu
primer
base
align
prototyp
sequenc
coronaviru
sequenc
figur
determin
whether
newli
design
pancoronaviru
rtpcr
assay
effici
amplifi
broad
rang
coronavirus
rtpcr
assay
test
cell
cultur
supernat
four
known
human
coronavirus
three
anim
coronavirus
sarscov
felin
infecti
periton
viru
fipv
porcin
hemagglutin
encephalomyel
viru
phev
murin
hepat
viru
mhv
amplif
expect
bp
region
observ
test
coronavirus
figur
sensit
pancoronaviru
rtpcr
assay
assess
test
tenfold
dilut
rna
copi
rna
copi
per
nasopharyng
aspir
could
detect
sensit
bit
lower
ie
rna
copi
per
nasopharyng
aspir
pancoronaviru
rtpcr
assay
use
screen
specimen
hospit
patient
respiratori
symptom
collect
januari
march
sampl
bp
fragment
could
amplifi
identifi
sequenc
use
pancoronaviru
primer
studi
specimen
tempor
distribut
correspond
yearli
rsv
epidem
period
figur
total
sampl
found
neg
rsv
diagnost
test
patient
studi
compris
patient
age
year
age
year
detect
sampl
one
posit
sampl
collect
end
januari
coinfect
rsv
type
b
present
five
posit
sampl
collect
within
tenday
period
end
februari
one
posit
sampl
collect
end
februari
show
coinfect
adenoviru
parainfluenza
viru
figur
tabl
seven
posit
sampl
obtain
one
patient
age
month
four
patient
year
one
patient
year
one
patient
year
patient
file
show
subject
suffer
respiratori
tract
ill
underli
diseas
tabl
seven
posit
respiratori
sampl
confirm
altern
rtpcr
assay
amplif
fragment
nucleocapsid
gene
carri
sequenc
analysi
n
gene
fragment
fragment
show
similar
prototyp
sequenc
avail
genbank
databas
third
onestep
rtpcr
carri
posit
sampl
amplifi
part
gene
sequenc
analysi
pcrproduct
reveal
sequenc
ident
prototyp
sequenc
avail
genbank
neighborjoin
phylogenet
tree
construct
base
align
nucleotid
sequenc
posit
sampl
avail
sequenc
genbank
use
outgroup
dendrogram
show
sequenc
cluster
togeth
two
subclust
observ
figur
inspect
two
full
genom
sequenc
avail
genbank
demonstr
especi
aminotermin
region
spike
protein
diverg
therefor
decid
amplifi
region
investig
variabl
region
patient
rtnest
pcr
assay
use
amplifi
part
gene
partial
spike
sequenc
show
similar
prototyp
strain
align
gene
sequenc
belgian
sampl
partial
spike
sequenc
posit
sampl
identifi
netherland
data
shown
prototyp
sequenc
use
constitut
neighborjoin
phylogenet
tree
neighborjoin
tree
evalu
bootstrap
pseudorepl
two
cluster
observ
figur
screen
sampl
collect
presenc
also
perform
detect
sampl
one
sampl
seven
posit
sampl
collect
winter
earli
spring
sampl
detect
collect
april
posit
sampl
confirm
rtpcr
use
specif
primer
pair
amplifi
part
gene
partial
membran
sequenc
contemporari
belgian
strain
show
similar
prototyp
sequenc
genbank
rsv
influenza
virus
adenovirus
parainfluenzavirus
probabl
import
viral
agent
sever
respiratori
diseas
howev
substanti
part
respiratori
tract
infect
attribut
known
pathogen
underli
condit
immunosuppress
larg
determin
impact
respiratori
virus
individu
common
cold
virus
also
associ
sever
lower
respiratori
tract
condit
infant
immunocompromis
patient
clinic
symptom
associ
infect
still
need
determin
indic
caus
sever
respiratori
ill
children
immunocompromis
adult
detect
use
pancoronaviru
rtpcr
patient
suffer
rel
sever
respiratori
diseas
necessit
hospit
posit
sampl
collect
children
age
month
year
two
patient
suffer
sever
underli
diseas
one
patient
suffer
smithlemliopitz
syndrom
rare
autosom
recess
disord
due
primari
enzymat
defect
cholesterol
metabol
second
patient
diagnos
vater
syndrom
character
sporad
associ
specif
birth
defect
abnorm
vertebra
vascular
anomali
anal
atresia
trachea
esophagu
problem
renal
anom
infect
patient
establish
complet
recoveri
respiratori
symptom
onestep
rtpcr
assay
use
detect
confirm
posit
sampl
result
epidemiolog
survey
conduct
led
conclus
human
coronavirus
distribut
worldwid
circul
season
outbreak
result
indic
causal
agent
signific
portion
respiratori
diseas
unknown
etiolog
detect
respiratori
sampl
collect
februari
frequenc
februari
frequenc
result
seem
support
tendenc
human
coronavirus
circul
mainli
winter
season
howev
studi
sampl
perform
januari
may
yearli
rsv
epidem
period
sampl
summer
autumn
month
screen
first
public
show
viru
circul
amsterdam
winter
month
recent
anoth
set
amsterdam
sampl
screen
obtain
winter
found
one
trachea
sampl
obtain
februari
two
oropharyng
aspir
decemb
januari
respect
data
shown
combin
data
present
belgium
find
confirm
reappear
winter
season
similar
previous
known
respiratori
virus
recent
research
team
australia
japan
canada
submit
partial
sequenc
genbank
databas
indic
newli
discov
human
coronaviru
worldwid
distribut
sequenc
analysi
highli
conserv
nucleocapsid
region
show
belgian
isol
similar
two
prototyp
complet
genom
sequenc
genbank
isol
netherland
furthermor
phylogenet
analysi
part
orf
region
patient
show
subclust
describ
previous
figur
find
support
suggest
sever
subtyp
distinct
molecular
marker
cocircul
also
belgium
larg
insert
part
gene
compar
describ
complet
genom
sequenc
show
sequenc
ident
spike
insert
region
impli
least
two
differ
subtyp
sequenc
analysi
spike
insert
region
reveal
sampl
show
similar
prototyp
subtyp
confirm
phylogenet
analysi
partial
gene
sequenc
cluster
togeth
two
prototyp
sequenc
two
differ
group
figur
confirm
subtyp
first
isol
cocircul
analys
dendrogram
base
gene
sequenc
discord
cluster
pattern
isol
eg
hcovnl
observ
suggest
possibl
recombin
event
research
complet
genom
sequenc
isol
requir
draw
conclus
base
phylogenet
analysi
one
singl
gene
therefor
requir
caution
true
phylogeni
demonstr
analys
complet
genom
sequenc
screen
sampl
collect
presenc
reveal
seven
posit
sampl
one
posit
sampl
posit
sampl
isol
winter
earli
spring
concord
result
previou
epidemiolog
studi
infect
sampl
mainli
identifi
februari
februari
figur
data
show
epidem
season
coincid
posit
sampl
collect
children
age
year
suffer
respiratori
symptom
low
detect
rate
compar
frequent
detect
might
impli
close
relat
current
import
causal
agent
respiratori
diseas
moment
data
concern
crossneutr
theori
crossneutr
might
possibl
sinc
virus
rel
close
relat
speci
belong
coronaviru
group
antigen
crossreact
alreadi
demonstr
sarscov
group
coronavirus
tgev
fipv
ccov
develop
pancoronaviru
rtpcr
assay
use
primer
set
match
known
coronavirus
might
use
identif
new
coronavirus
pancoronaviru
rtpcrassay
also
use
diagnost
tool
detect
four
current
known
human
coronavirus
clinic
sampl
human
coronaviru
new
import
respiratori
pathogen
caus
sever
respiratori
infect
children
sequenc
analysi
isol
detect
studi
demonstr
belgian
isol
classifi
two
subtyp
correspond
two
prototyp
sequenc
isol
netherland
find
indic
two
subtyp
may
current
cocircul
author
declar
compet
interest
em
conceiv
studi
design
togeth
lv
ek
mvr
em
develop
pancoronaviru
rtpcr
perform
rtpcr
sequenc
reaction
em
lv
draft
manuscript
kz
assembl
respiratori
sampl
sl
perform
rtpcr
sensit
assay
pm
respons
graphic
support
manuscript
lvdh
kp
bb
develop
rtpcr
help
design
studi
write
manuscript
author
contribut
final
version
manuscript
read
approv
prepubl
histori
paper
access
